OverviewChartNewsTraderScreen

UC BON.CAP.CERT. 03/25 AMD/  DE000HD41ZD9  /

gettex
2024-05-31  9:46:09 PM Chg.-0.270 Bid9:59:48 PM Ask9:59:48 PM Underlying Strike price Expiration date Option type
160.940EUR -0.17% 162.040
Bid Size: 500		 162.080
Ask Size: 500		 ADVANCED MIC.DEV. D... - - 2025-03-28 Call
GlobeNewswire 2:35 PM Computer Industry Joins NVIDIA to Build AI Factories and Data Centers for the Next Industrial Revolu...
GlobeNewswire 05-29 GRANITESHARES SURPASSES $5B AUM AS TRADING VOLUMES SURGE
GlobeNewswire 05-29 Alkeus Pharmaceuticals Appoints Eric L. Trachtenberg as Chief Legal Officer
GlobeNewswire 05-28 AMD Chair and Chief Executive Officer Dr. Lisa Su to Deliver the Opening Keynote at Computex 2024
GlobeNewswire 05-28 Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizuma...
GlobeNewswire 05-28 Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire 05-21 AMD Instinct MI300X Accelerators Power Microsoft Azure OpenAI Service Workloads and New Azure ND MI3...
GlobeNewswire 05-21 AMD Expands EPYC CPU Portfolio to Bring New Levels of Performance and Value for Small and Medium Bus...
GlobeNewswire 05-21 Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire 05-21 YieldMax™ Launches Option Income Strategy ETF on the VanEck® Gold Miners ETF (GDX®)
TeleTrader 05-20 Microsoft will 'soon welcome' AMD, Intel chips
GlobeNewswire 05-20 Broadcom Revolutionizes AI Networking Landscape with High-Performance 400G RoCE/RDMA Ethernet NICs
Newsfile Corp 05-16 FDA Grants AI-Powered Notal Vision Home OCT "SCANLY" De Novo Marketing Authorization
GlobeNewswire 05-15 Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Cor...
GlobeNewswire 05-14 AMD Announces Upcoming Events for the Financial Community
GlobeNewswire 05-14 Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facilit...
GlobeNewswire 05-14 Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
GlobeNewswire 05-14 Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 05-13 Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5...
GlobeNewswire 05-13 AMD Remains the Partner of Choice for World’s Fastest and Most Efficient High Performance Computing ...
GlobeNewswire 05-09 Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 05-09 Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlight...
GlobeNewswire 05-09 4DMT Reports First Quarter 2024 Financial Results and Operational Highlights
GlobeNewswire 05-08 Alkeus Pharmaceuticals Announces Positive Interim Results Demonstrating No Signs of Disease Progress...
GlobeNewswire 05-08 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...